The global immune thrombocytopenia treatment market is experiencing a period of significant development. This situation can be attributed to several factors, including an rising prevalence of immune thrombocytopenia worldwide and the launch of novel treatment therapies. Moreover, advancements in diagnostic technologies are enabling earlier diagnosi